Skip to content

Virtual Hypertension Management Pilot

Virtual Hypertension Management Pilot: Randomized Evaluation of Electronic Health Record-connected Blood Pressure Cuffs in a Clinical Pharmacist Panel.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03291535
Enrollment
75
Registered
2017-09-25
Start date
2017-07-26
Completion date
2022-03-01
Last updated
2022-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digital Health, Electronic Health Record, Hypertension

Brief summary

Investigators are examining the quality improvement impact of providing patients with a an electronic health record-connected blood pressure cuff. Investigators will give half of patients already eligible for hypertension management within a clinical pharmacist panel, the ability to upload their blood pressure data into Stanford's electronic health record.

Interventions

OTHERConnected-device

This intervention will allow patients to upload blood pressure data automatically from a blood pressure cuff into the electronic health record.

OTHERUsual care

This intervention will consist of usual clinical care as determined by the clinical pharmacist.

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Hypertension as defined by clinical pharmacist usual care panel (2 or more readings of blood pressure \>140/90)

Exclusion criteria

* Pregnancy * Chronic kidney disease III or IV * Systolic heart failure with ejection fraction \<35% * Current use of 3 or more anti-hypertension drugs

Design outcomes

Primary

MeasureTime frameDescription
Change in blood pressure over time in control group vs. the intervention groupFrom enrollment to 6 months laterDifference in the change in blood pressure between the control group and intervention group.

Secondary

MeasureTime frameDescription
Patient visitsFrom enrollment to 6 months laterMeasurement of the number of in-person visits
Patient remote interactionsFrom enrollment to 6 months laterMeasurement of the number of patient phone calls plus patient-portal messages to the clinical pharmacist
Medication changesFrom enrollment to 6 months laterNumber of changes in medication or medication dose
Blood pressure controlFrom enrollment to 6 months laterTime to reach target blood pressure control (Adults 18-59 years of age \<140/90 mm Hg, Adults 60-85 years of age, without a diagnosis of diabetes, \<150/90 mm Hg, Adults 60-85 years of age, with a diagnosis of diabetes, \<140/90 mm Hg)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026